FTRE

#2533
Fortrea Holdings Inc. Common Stock
9.59 USD
+2.24%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
9.59
9.59
Годовой диапазон
3.97
18.67
Дневное изменение
+2.24%
Месячное изменение
+1.48%
6-месячное изменение
-0.62%
Годовое изменение
+80.94%
Предыдущее закрытие
9.38
Открыть
9.59
Bid
Ask
Минимум
9.59
High
9.59
Объем
98
Открыть полный график

Financials

Обзор Отчетность Статистика
Квартал Год
  • Market Capitalization 896.66 M
  • Employee 14 K
  • Founded 2023
  • CEO Paul R. N. Kirchgraber
  • Website www.fortrea.com
  • Headquarter North Carolina, United States
  • FIGI BBG01GZF9VY6
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
-1.6
Коэффициент цена/денежный поток
—

Fortrea Holdings Inc

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates.

Новости